Palatin Technologies Inc Sustainability Reports
Palatin Technologies, Inc. is a biopharmaceutical company engaged in developing first-class medicines based on molecules that modulate the activity of the melanocortin receptor system. Its product pipeline targets diseases with significant unmet medical need, including inflammation, autoimmune disorders, and retinal diseases.
Sector: Manufacturing
Country: United States
Exchange: London Stock Exchange
LEI: 549300IDN7TWMQI0JP93
FIGI: BBG001S8HM57
6 reports from 2007 to 2023
